Cargando…
Response to ‘The effect of PD-L1 testing on the cost-effectiveness of immune checkpoint inhibitors’
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6225827/ https://www.ncbi.nlm.nih.gov/pubmed/30052727 http://dx.doi.org/10.1093/annonc/mdy260 |
_version_ | 1783369857741357056 |
---|---|
author | Ogale, S |
author_facet | Ogale, S |
author_sort | Ogale, S |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-6225827 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-62258272018-11-14 Response to ‘The effect of PD-L1 testing on the cost-effectiveness of immune checkpoint inhibitors’ Ogale, S Ann Oncol Letters to the Editor Oxford University Press 2018-10 2018-07-20 /pmc/articles/PMC6225827/ /pubmed/30052727 http://dx.doi.org/10.1093/annonc/mdy260 Text en © The Author(s) 2018. Published by Oxford University Press on behalf of the European Society for Medical Oncology. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Letters to the Editor Ogale, S Response to ‘The effect of PD-L1 testing on the cost-effectiveness of immune checkpoint inhibitors’ |
title | Response to ‘The effect of PD-L1 testing on the cost-effectiveness of immune checkpoint inhibitors’ |
title_full | Response to ‘The effect of PD-L1 testing on the cost-effectiveness of immune checkpoint inhibitors’ |
title_fullStr | Response to ‘The effect of PD-L1 testing on the cost-effectiveness of immune checkpoint inhibitors’ |
title_full_unstemmed | Response to ‘The effect of PD-L1 testing on the cost-effectiveness of immune checkpoint inhibitors’ |
title_short | Response to ‘The effect of PD-L1 testing on the cost-effectiveness of immune checkpoint inhibitors’ |
title_sort | response to ‘the effect of pd-l1 testing on the cost-effectiveness of immune checkpoint inhibitors’ |
topic | Letters to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6225827/ https://www.ncbi.nlm.nih.gov/pubmed/30052727 http://dx.doi.org/10.1093/annonc/mdy260 |
work_keys_str_mv | AT ogales responsetotheeffectofpdl1testingonthecosteffectivenessofimmunecheckpointinhibitors |